On Invalid Date, Elevance Health (NYSE: ELV) reported Q1 2024 earnings per share (EPS) of $9.65, up 15.29% year over year. Total Elevance Health earnings for the quarter were $2.25 billion. In the same quarter last year, Elevance Health's earnings per share (EPS) was $8.37.
As of Q2 2024, Elevance Health's earnings has grown 4.43% year over year. This is 12.74 percentage points higher than the US Healthcare Plans industry earnings growth rate of -8.31%. Elevance Health's earnings in the past year totalled $6.24 billion.
What was ELV's revenue last quarter?
On Invalid Date, Elevance Health (NYSE: ELV) reported Q1 2024 revenue of $42.58 billion up 0.96% year over year. In the same quarter last year, Elevance Health's revenue was $42.17 billion.
What was ELV's revenue growth in the past year?
As of Q2 2024, Elevance Health's revenue has grown 6.89% year over year. This is 4.75 percentage points lower than the US Healthcare Plans industry revenue growth rate of 11.64%. Elevance Health's revenue in the past year totalled $171.75 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.